Artico M, Corelli F, Massa S, Stefancich G, Avigliano L, Befani O, Marcozzi G, Sabatini S, Mondovi B
Istituto di Chimica Farmaceutica e Tossicologica, Università di Roma "La Sapienza", Italy.
J Med Chem. 1988 Apr;31(4):802-6. doi: 10.1021/jm00399a021.
Some hydrazides of pyrrol-1-ylbenzoic and pyrrol-1-ylphenylacetic acids were prepared, and their effect on copper-dependent amine oxidases (Cu-AOs) and FAD monoamine oxidases (MAOs) activities was tested. The compounds were not substrates for Cu-AO enzymes but acted as noncompetitive inhibitors. Hydrazides of pyrrol-1-ylphenylacetic acids were highly specific for plasma amine oxidase (Ki = 0.5-1 microM). In contrast, all the hydrazides were weak inhibitors of MAO activity. Incubation with the hydrazide derivatives led to irreversible inactivation of Cu-AOs. Therefore, the inhibition implied two distinct steps. The first one consisted of the rapid formation of the enzyme-inhibitor complex and was reversed by dialysis. In the second step, the complex was irreversibly transformed, probably by the formation of a Schiff base between the hydrazide and the prosthetic carbonyl group of the enzyme.
制备了一些吡咯-1-基苯甲酸和吡咯-1-基苯乙酸的酰肼,并测试了它们对铜依赖性胺氧化酶(Cu-AOs)和黄素腺嘌呤二核苷酸单胺氧化酶(MAOs)活性的影响。这些化合物不是Cu-AO酶的底物,但可作为非竞争性抑制剂。吡咯-1-基苯乙酸的酰肼对血浆胺氧化酶具有高度特异性(Ki = 0.5 - 1 microM)。相比之下,所有酰肼都是MAO活性的弱抑制剂。与酰肼衍生物孵育会导致Cu-AOs不可逆失活。因此,这种抑制作用涉及两个不同的步骤。第一步是酶-抑制剂复合物的快速形成,可通过透析逆转。在第二步中,复合物发生不可逆转化,可能是由于酰肼与酶的辅基羰基之间形成了席夫碱。